V. Sigurdardottir

发表

Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study)

B. Fagerberg, J. Hulthe, V. Sigurdardottir, 2002, Journal of internal medicine.

Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis

B. Fagerberg, O. Wiklund, A. Gummesson, 2008, Journal of internal medicine.

Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels.

P. Aukrust, J. Goetze, L. Gullestad, 2014, Biomarkers in medicine.

Heart rate kinetics during standard cardiopulmonary exercise testing in heart transplant recipients: a longitudinal study

M. Wilhelm, P. Mohacsi, D. Herzig, 2021, ESC heart failure.

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

V. Friman, N. Selimovic, R. Andersson, 2015, BMC Infectious Diseases.

Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography

L. Räber, S. Windecker, Y. Ueki, 2018, PloS one.

Development of an international Core Outcome Set (COS) for best care for the dying person: study protocol

D. Haugen, A. van der Heide, L. van Zuylen, 2020, BMC Palliative Care.

Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.

P. Aukrust, L. Gullestad, M. Iversen, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies.

J. Lommi, H. Eiskjær, F. Gustafsson, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61‐year‐old men

B. Fagerberg, J. Wikstrand, J. Hulthe, 2008, Scandinavian journal of clinical and laboratory investigation.

CYP3A5*3 and POR*28 Genetic Variants Influence the Required Dose of Tacrolimus in Heart Transplant Recipients

T. Carrel, G. Fiedler, C. Largiadèr, 2014, Therapeutic drug monitoring.

Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement

U. Christians, Chris Nakas, A. Leichtle, 2017, Metabolomics.

Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial

H. Bøtker, A. Ragnarsson, T. Ueland, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial

H. Bøtker, G. Dellgren, G. Rådegran, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial

G. Dellgren, G. Rådegran, B. Andersson, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation

G. Fiedler, C. Largiadèr, P. Mohacsi, 2015, Clinical transplantation.

Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?

L. Potena, H. Lehmkuhl, S. Varnous, 2013, Transplantation reviews.

Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men.

B. Fagerberg, J. Wikstrand, J. Hulthe, 2007, Atherosclerosis.

Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed diabetes and established diabetes.

B. Fagerberg, J. Hulthe, V. Sigurdardottir, 2004, Diabetes care.

Cytomegalovirus infection and disease 3 reduce 10-year cardiac allograft 4 vasculopathy-free survival in heart 5 transplant recipients

V. Friman, N. Selimovic, R. Andersson, 2015 .

[Better and better results of heart transplantation. Analysis of 25 years of collected experiences].

G. Dellgren, K. Karason, L. Wiklund, 2009, Lakartidningen.

Endothelial cell antibody-mediated rejection and successful retransplantation in a heart transplanted patient.

G. Dellgren, V. Sigurdardottir, O. Kolsrud, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study).

B. Fagerberg, J. Hulthe, V. Sigurdardottir, 2002 .